Historical Valuation
Applied Therapeutics Inc (APLT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.06. The fair price of Applied Therapeutics Inc (APLT) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.10
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Applied Therapeutics Inc (APLT) has a current Price-to-Book (P/B) ratio of -26.42. Compared to its 3-year average P/B ratio of -11.11 , the current P/B ratio is approximately 137.79% higher. Relative to its 5-year average P/B ratio of -5.30, the current P/B ratio is about 398.26% higher. Applied Therapeutics Inc (APLT) has a Forward Free Cash Flow (FCF) yield of approximately -586.02%. Compared to its 3-year average FCF yield of -88.09%, the current FCF yield is approximately 565.27% lower. Relative to its 5-year average FCF yield of -95.66% , the current FCF yield is about 512.59% lower.
P/B
Median3y
-11.11
Median5y
-5.30
FCF Yield
Median3y
-88.09
Median5y
-95.66
Competitors Valuation Multiple
AI Analysis for APLT
The average P/S ratio for APLT competitors is 6.37, providing a benchmark for relative valuation. Applied Therapeutics Inc Corp (APLT.O) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of 719.67%, this premium appears sustainable.
Performance Decomposition
AI Analysis for APLT
1Y
3Y
5Y
Market capitalization of APLT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of APLT in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is APLT currently overvalued or undervalued?
Applied Therapeutics Inc (APLT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.06. The fair price of Applied Therapeutics Inc (APLT) is between to according to relative valuation methord.
What is Applied Therapeutics Inc (APLT) fair value?
APLT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Applied Therapeutics Inc (APLT) is between to according to relative valuation methord.
How does APLT's valuation metrics compare to the industry average?
The average P/S ratio for APLT's competitors is 6.37, providing a benchmark for relative valuation. Applied Therapeutics Inc Corp (APLT) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of 719.67%, this premium appears sustainable.
What is the current P/B ratio for Applied Therapeutics Inc (APLT) as of Jan 09 2026?
As of Jan 09 2026, Applied Therapeutics Inc (APLT) has a P/B ratio of -26.42. This indicates that the market values APLT at -26.42 times its book value.
What is the current FCF Yield for Applied Therapeutics Inc (APLT) as of Jan 09 2026?
As of Jan 09 2026, Applied Therapeutics Inc (APLT) has a FCF Yield of -586.02%. This means that for every dollar of Applied Therapeutics Inc’s market capitalization, the company generates -586.02 cents in free cash flow.
What is the current Forward P/E ratio for Applied Therapeutics Inc (APLT) as of Jan 09 2026?
As of Jan 09 2026, Applied Therapeutics Inc (APLT) has a Forward P/E ratio of -0.22. This means the market is willing to pay $-0.22 for every dollar of Applied Therapeutics Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Applied Therapeutics Inc (APLT) as of Jan 09 2026?
As of Jan 09 2026, Applied Therapeutics Inc (APLT) has a Forward P/S ratio of 0.00. This means the market is valuing APLT at $0.00 for every dollar of expected revenue over the next 12 months.